Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2011 by HaEmek Medical Center, Israel.
Recruitment status was:  Not yet recruiting
Information provided by:
HaEmek Medical Center, Israel Identifier:
First received: January 4, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
vaginal PH has an effect on the effectiveness of treatment with misoprostol given vaginally for missed abortions in the first trimester

Condition Intervention
Other: PH meassurment

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions

Resource links provided by NLM:

Further study details as provided by HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • treatment failure- need for D&C [ Time Frame: 2 weeks ]

Secondary Outcome Measures:
  • side effects, need foe analgetics, time for compliting abortion [ Time Frame: 2 weeks ]

Estimated Enrollment: 400
Study Start Date: February 2011
Groups/Cohorts Assigned Interventions
ph above cutoff Other: PH meassurment
meassuring ph USING PROBE
PH under cutoff Other: PH meassurment
meassuring ph USING PROBE


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
women dignosed with missed abortion in the first trimester


  • missed abortion under 8 weeks by sac diameter over 18 years old informed concent given

Exclusion Criteria:

  • missed abortion over 8 weeks hypersensitivity for PG vaginal bleeding suspected EUP IUD heart disease, HTN, cerebral vascular disease, epilepsy intrauterine infection clooting disorder under 18
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01270334

Contact: shira baram, dr 972-4-6494035

Haemel Medical Center Not yet recruiting
Afula, Israel
Contact: shira baram, md    972-4-6494035      
Principal Investigator: shira baram, md         
Sponsors and Collaborators
HaEmek Medical Center, Israel
  More Information

Responsible Party: doctor baram shira, HaEmek Medical Center Identifier: NCT01270334     History of Changes
Other Study ID Numbers: cytoph
Study First Received: January 4, 2011
Last Updated: January 4, 2011

Additional relevant MeSH terms:
Abortion, Missed
Abortion, Spontaneous
Pregnancy Complications
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics processed this record on May 25, 2017